Home /  All blogs

Certificate for highly cited research


The editors of Tuberculosis are delighted to inform you that your paper, Diagnosis of active tuberculosis by e-nose analysis of exhaled air, published in 2013, is one of the most highly cited papers during 2014 and 2015.  We would like to take this opportunity to thank you for publishing with us, and congratulate you.

Zorginnovatieprijs 2016 nominatie

The eNose Company is met de Aeonose® genomineerd voor  de Zorginnovatieprijs 2016!

De prijs wordt uitgereikt op het Health Valley Event op 17 maart 2016. Het Health Valley Event is het grootste jaarlijkse congres op het gebied van zorginnovatie en trekt meer dan 1000 deelnemers. Tijdens het plenaire slotprogramma krijgen de drie genomineerde zorginnovaties de kans zich aan het grote publiek te presenteren. Het publiek in de zaal kiest uiteindelijk het winnende bedrijf.


Diagnosing gastrointestinal illnesses using fecal headspace volatile organic compounds


fecal VOC analysis with Aetholab

“In our own experience, we used the Aetholab, a commercial electronic nose device (The eNose Company, Zutphen, Netherlands) in a preliminary study of 20 C. difficile PCR-positive stool and 53 C. difficile PCR-negative stool. In a similar approach using an artificial neural network for pattern recognition, we were able to classify the stool with 80% sensitivity, 85% specificity, and 84% accuracy.”

46th World Conference on Lung Health

At the 46th World Conference on Lung Health, Cape Town, South Africa (December 2-6, 2015), results from two Aeonose studies on TB were presented:

EP-138-04: Diagnosis of pulmonary and extra-pulmonary tuberculosis in Paraguay using the electronic nose (Paranose study) by R. Coronel et al,

86 participants were evaluated in 2015, 41 patients suffered from pulmonary TB and 45 were healthy controls. Preliminary analyses show sensitivity of 93% and specificity of 89 %.
A paper is in preparation.

EP-212-0: A new tuberculosis-screening tool: a hand-held electronic nose. A cross-sectional field study in Indonesia by A.M. Saktiawati et al.

87 participants from 5 groups (20 TB patients, 20 TB suspects who were later diagnosed as non TB, 20 non-TB patients, 20 healthy matched controls, and 7 MDR-TB patients) have been investigated showing a sensitivity of 92% and a specificity of 88%. More participants are being included.


Page 1 of 41234>

eNose tweets

ElectronicNose @ElectronicNose
eNose  @ElectronicNose
Mayo Clinic presenting at DDW Chicago next week on Aeonose results Barrett's https://t.co/9Vqu0nhnt3 
eNose  @ElectronicNose
Mayo Clinic presenting at DDW Chicago next week on Aeonose results Fasting https://t.co/3jX23nhFZ4 
eNose  @ElectronicNose
New publication on Automatic detection of oestrus cows via breath sampling with an electronic nose:… https://t.co/r3hdSajUjN